Alcon Revenue 2011-2026 | ALC

Company revenue is the total amount of money received from the sale of goods or services over a certain period of time. It is one of the key indicators of a company's financial condition and success.

Traditionally defined as follows:
Revenue = Price * Quantity of products

Revenue is one of the components of a company’s income. In international practice, revenue is understood as the inflow or other increase in a company's assets or the settlement of its obligations that occurs as a result of the company’s core or main activity.^[1]

This is an important indicator for assessing the financial condition and efficiency of a company. It makes it possible to determine how successfully a company sells its products or services on the market. In addition, revenue can be used to calculate other financial indicators such as profit, profitability, and market share.

Various factors can influence this indicator, including demand for goods or services, market competition, economic conditions, and the company's marketing efforts. Therefore, its analysis and monitoring are important tasks for the successful development of a business.

Annual Revenue Alcon

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
10.4 B	9.91 B	9.46 B	8.72 B	8.29 B	6.83 B	7.51 B	7.15 B	6.79 B	6.6 B	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
10.4 B	6.6 B	8.17 B

Quarterly Revenue Alcon

2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	-	-	-	-	2.11 B	-	-	-	1.21 B	-	-	-	1.9 B	-	-	-	1.82 B	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
2.11 B	1.21 B	1.76 B

References

Adhikari, B. (2010). Impact of Revenue Planning In Nepal Investment Bank Limited (Doctoral dissertation, Faculty of Management).

Revenue of other stocks in the Medical instruments industry

Issuer	Revenue	Price	% 24h	Market Cap	Country
Atrion Corporation ATRI	169 M	-	-	$ 810 M	USA
The Cooper Companies COO	4.09 B	$ 62.02	2.78 %	$ 12.3 B	USA
Luminex Corporation LMNX	417 M	-	-	$ 1.75 B	USA
Glaukos Corporation GKOS	507 M	$ 121.69	7.24 %	$ 6.96 B	USA
Akers Biosciences, Inc. AKER	1.58 M	-	-9.52 %	$ 20.6 M	USA
Intuitive Surgical ISRG	10.1 B	$ 418.82	2.83 %	$ 149 B	USA
ICU Medical ICUI	2.23 B	$ 134.93	3.38 %	$ 3.32 B	USA
Repro Med Systems KRMD	41.1 M	$ 4.14	5.61 %	$ 191 M	USA
iRhythm Technologies IRTC	747 M	$ 107.35	2.67 %	$ 3.44 B	USA
LeMaitre Vascular LMAT	250 M	-	-	$ 2.12 B	USA
Masimo Corporation MASI	2.09 B	$ 178.9	0.07 %	$ 9.54 B	USA
Antares Pharma, Inc. ATRS	150 M	-	-	$ 955 M	USA
Cantel Medical Corp. CMD	1.02 B	-	-1.18 %	$ 3.4 B	USA
CRH Medical Corporation CRHM	106 M	-	-	$ 282 M	USA
Hill-Rom Holdings, Inc. HRC	2.88 B	-	-0.05 %	$ 10.3 B	USA
Microbot Medical MBOT	117 K	-	-	$ 89.7 M	Israel
Ekso Bionics Holdings EKSO	12.8 M	-	-	$ 28.6 M	USA
Milestone Scientific MLSS	8.97 M	$ 0.43	11.28 %	$ 35.3 M	USA
Varian Medical Systems, Inc. VAR	3.17 B	-	-0.02 %	$ 16.3 B	USA
electroCore ECOR	32 M	$ 9.94	0.81 %	$ 84.3 K	USA
Envista Holdings Corporation NVST	2.72 B	$ 22.87	2.1 %	$ 3.84 B	USA
Haemonetics Corporation HAE	1.33 B	$ 69.85	6.03 %	$ 3.3 B	USA
Isoray ISR	1.43 M	-	0.03 %	$ 108 M	USA
STERIS plc STE	5.94 B	$ 212.24	0.98 %	$ 20.8 B	USA
STAAR Surgical Company STAA	239 M	$ 29.86	5.66 %	$ 1.48 B	USA
InfuSystem Holdings INFU	143 M	$ 9.12	1.0 %	$ 188 M	USA
Teleflex Incorporated TFX	569 M	$ 132.11	2.76 %	$ 5.9 B	USA
Merit Medical Systems MMSI	1.52 B	$ 63.04	3.94 %	$ 3.73 B	USA
Utah Medical Products UTMD	9.04 M	$ 67.99	3.75 %	$ 220 M	USA
West Pharmaceutical Services WST	3.07 B	$ 317.32	0.32 %	$ 22.9 B	USA
DENTSPLY SIRONA XRAY	3.68 B	$ 9.88	2.49 %	$ 1.97 B	USA
Pulse Biosciences PLSE	350 K	$ 26.94	7.8 %	$ 1.82 B	USA
Retractable Technologies RVP	38.3 M	$ 0.66	0.41 %	$ 19.8 M	USA
Pro-Dex PDEX	66.6 M	$ 67.0	2.81 %	$ 220 M	USA
Predictive Oncology POAI	125 K	-	-	$ 31.1 M	USA
BioLife Solutions BLFS	96.2 M	-	-	$ 1.29 B	USA
Stereotaxis STXS	32.4 M	$ 1.88	2.17 %	$ 171 M	USA
Baxter International BAX	11.2 B	$ 19.35	4.31 %	$ 9.93 B	USA
ResMed RMD	3.58 B	$ 194.32	4.2 %	$ 28.4 B	USA
AtriCure ATRC	535 M	-	-	$ 1.3 B	USA
Harvard Bioscience HBIO	86.6 M	-	-	$ 288 M	USA
NeuroMetrix NURO	3.03 M	-	5.05 %	$ 9.02 M	USA
AngioDynamics ANGO	292 M	$ 12.03	7.41 %	$ 491 M	USA
Becton, Dickinson and Company BDX	21.8 B	$ 149.56	2.73 %	$ 43 B	USA
Nephros NEPH	18.8 M	$ 3.59	-1.37 %	$ 38.1 M	USA
OraSure Technologies OSUR	115 M	$ 4.17	5.57 %	$ 306 M	USA
Repligen Corporation RGEN	738 M	$ 126.55	3.96 %	$ 7.12 M	USA